Tenecteplase can be given to patients with intermediate-risk pulmonary embolism--but should it?
Lankeit
Mareike
M
Konstantinides
Stavros
S
D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000503:physiopathology; D012307:Risk Factors; D000077785:Tenecteplase; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase